4//SEC Filing
Rossi Michael J 4
Accession 0001415889-24-003743
CIK 0001722964other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:30 PM ET
Size
16.8 KB
Accession
0001415889-24-003743
Insider Transaction Report
Form 4
Rossi Michael J
DirectorPRESIDENT & CEO
Transactions
- Award
Common Stock
2024-02-12+35,700→ 35,700 total - Award
Employee Stock Option (right to buy)
2024-02-12+214,200→ 214,200 totalExercise: $14.36Exp: 2034-02-12→ Common Stock (214,200 underlying) - Award
Restricted Stock Units
2024-02-12+54,000→ 54,000 total→ Common Stock (54,000 underlying)
Footnotes (5)
- [F1]Represents 35,750 restricted stock units ("RSUs") granted to the Reporting Person pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc. Each RSU represents a contingent right to receive one share of Common Stock on the vesting dates of the RSU. The RSUs vest by 1/3 on each of February 12, 2025, February 12, 2026 and February 12, 2027 subject to the continuing employment of the Reporting Person through each vesting date.
- [F2]Stock options granted to the Reporting Person pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc.
- [F3]The stock options shall vest and become exercisable as to 25% of the shares subject to the option on February 12, 2025, and thereafter vest and become exercisable as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person through each vesting date.
- [F4]Performance-Based RSUs ("PRSUs") granted to the Reporting Person pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc. Each PRSU represents a contingent right to receive one share of Common Stock on the vesting dates of the PRSU.
- [F5]1/3 of the PRSUs vest on each of February 12, 2025, February 12, 2026 and February 12, 2027, in each case, if the average closing price per share of the Issuer's common stock over the preceding 30 trading day period is greater or equal to $10.00 per share, subject to the continuing employment of the Reporting Person through each vesting date.
Documents
Issuer
Y-mAbs Therapeutics, Inc.
CIK 0001722964
Entity typeother
Related Parties
1- filerCIK 0001948795
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 4:30 PM ET
- Size
- 16.8 KB